Nicola Waddell, Growth and Operations Manager, has over 20 years of experience in the pharmaceutical industry, specializing in sales, learning and development, strategic account management, and market access. Prior to joining Pharmacoevidence in 2024, she led market access research projects in consultancy. Nicola has experience across a wide range of disease areas, including mental health, respiratory, cardiovascular, and rare diseases, and is recognized for her collaborative approach and commitment to successful project execution.
Established in 2020, Pharmacoevidence has grown into a recognized leader in pharmaceutical research, guided by a steadfast focus on innovation and patient well‑
Pharmacoevidence’s Generative AI Products empower life sciences organizations to generate high-quality evidence with speed and precision. From automated SLRs to HTA review simulations, our intelligent platforms minimize manual effort, enhance analytical accuracy, and support strategic market access decisions.
